Offerings / Regulation CF / Mahzi Therapeutics, Inc.
Mahzi Therapeutics, Inc.
Regulation Crowdfunding offering on Wefunder · Form C filed June 17, 2026 · South San Francisco, California
Repeat issuerPreferredPre-revenueCorporation, Delaware
Business summary pending extraction from the offering statement. The company is a corporation organized in Delaware on June 30, 2020, based in South San Francisco, CA, with 14 employees and $0 of revenue in its most recent fiscal year.
Offering terms
- Security
- Preferred Stock
- Maximum
- $1,200,000.00
- Price
- $3.47 per unit
- Pricing method
- Dividing pre-money valuation $87,900,000.00 by number of shares outstanding on fully diluted basis.
- Deadline
- December 31, 2026
- Oversubscriptions
- Accepted
- Intermediary
- Wefunder Portal LLC
Funding portal, SEC file 007-00033 - Intermediary fee
- 5.0% of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.
- Intermediary equity
- No
- Co-issuer
- Mahzi Therapeutics, Inc I, a series of Wefunder SPV, LLC
Financials as filed
| Item | Most recent FY | Prior FY |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of goods sold | $0 | $0 |
| Net income (loss) | -$18,656,306 | -$11,885,773 |
| Total assets | $11,638,540 | $18,971,450 |
| Cash and equivalents | $10,695,753 | $10,260,277 |
| Accounts receivable | $0 | $0 |
| Short-term debt | $6,760,112 | $2,058,254 |
| Long-term debt | $1,137,377 | $0 |
| Taxes paid | $0 | $0 |
Two fiscal years as reported on the Form C cover sheet. 14 employees. Offered in 56 states.